187 related articles for article (PubMed ID: 35743105)
21. Dystroglycan: a possible mediator for reducing congenital muscular dystrophy?
Sciandra F; Gawlik KI; Brancaccio A; Durbeej M
Trends Biotechnol; 2007 Jun; 25(6):262-8. PubMed ID: 17416431
[TBL] [Abstract][Full Text] [Related]
22. Tumor suppressor function of laminin-binding alpha-dystroglycan requires a distinct beta3-N-acetylglucosaminyltransferase.
Bao X; Kobayashi M; Hatakeyama S; Angata K; Gullberg D; Nakayama J; Fukuda MN; Fukuda M
Proc Natl Acad Sci U S A; 2009 Jul; 106(29):12109-14. PubMed ID: 19587235
[TBL] [Abstract][Full Text] [Related]
23. AGO61-dependent GlcNAc modification primes the formation of functional glycans on α-dystroglycan.
Yagi H; Nakagawa N; Saito T; Kiyonari H; Abe T; Toda T; Wu SW; Khoo KH; Oka S; Kato K
Sci Rep; 2013 Nov; 3():3288. PubMed ID: 24256719
[TBL] [Abstract][Full Text] [Related]
24. A tumor suppressor function of laminin-binding alpha-dystroglycan.
Bao X; Fukuda M
Methods Enzymol; 2010; 479():387-96. PubMed ID: 20816178
[TBL] [Abstract][Full Text] [Related]
25. A conditional-lethal mutant of bacillus subtilis 168 with a thermosensitive glycerol-3-phosphate cytidylyltransferase, an enzyme specific for the synthesis of the major wall teichoic acid.
Pooley HM; Abellan FX; Karamata D
J Gen Microbiol; 1991 Apr; 137(4):921-8. PubMed ID: 1649892
[TBL] [Abstract][Full Text] [Related]
26. High throughput screening for compounds that alter muscle cell glycosylation identifies new role for N-glycans in regulating sarcolemmal protein abundance and laminin binding.
Cabrera PV; Pang M; Marshall JL; Kung R; Nelson SF; Stalnaker SH; Wells L; Crosbie-Watson RH; Baum LG
J Biol Chem; 2012 Jun; 287(27):22759-70. PubMed ID: 22570487
[TBL] [Abstract][Full Text] [Related]
27. The inside and out of dystroglycan post-translational modification.
Moore CJ; Winder SJ
Neuromuscul Disord; 2012 Nov; 22(11):959-65. PubMed ID: 22770978
[TBL] [Abstract][Full Text] [Related]
28. Large induces functional glycans in an O-mannosylation dependent manner and targets GlcNAc terminals on alpha-dystroglycan.
Hu Y; Li ZF; Wu X; Lu Q
PLoS One; 2011 Feb; 6(2):e16866. PubMed ID: 21347376
[TBL] [Abstract][Full Text] [Related]
29. HNK-1 sulfotransferase modulates α-dystroglycan glycosylation by 3-O-sulfation of glucuronic acid on matriglycan.
Sheikh MO; Venzke D; Anderson ME; Yoshida-Moriguchi T; Glushka JN; Nairn AV; Galizzi M; Moremen KW; Campbell KP; Wells L
Glycobiology; 2020 Sep; 30(10):817-829. PubMed ID: 32149355
[TBL] [Abstract][Full Text] [Related]
30. Breast cancer cells adapt to metabolic stress by increasing ethanolamine phospholipid synthesis and CTP:ethanolaminephosphate cytidylyltransferase-Pcyt2 activity.
Zhu L; Bakovic M
Biochem Cell Biol; 2012 Apr; 90(2):188-99. PubMed ID: 22339418
[TBL] [Abstract][Full Text] [Related]
31. Endogenous glucuronyltransferase activity of LARGE or LARGE2 required for functional modification of α-dystroglycan in cells and tissues.
Inamori K; Willer T; Hara Y; Venzke D; Anderson ME; Clarke NF; Guicheney P; Bönnemann CG; Moore SA; Campbell KP
J Biol Chem; 2014 Oct; 289(41):28138-48. PubMed ID: 25138275
[TBL] [Abstract][Full Text] [Related]
32. α-Dystroglycan hypoglycosylation affects cell migration by influencing β-dystroglycan membrane clustering and filopodia length: A multiscale confocal microscopy analysis.
Palmieri V; Bozzi M; Signorino G; Papi M; De Spirito M; Brancaccio A; Maulucci G; Sciandra F
Biochim Biophys Acta Mol Basis Dis; 2017 Sep; 1863(9):2182-2191. PubMed ID: 28572004
[TBL] [Abstract][Full Text] [Related]
33. Human natural killer-1 sulfotransferase (HNK-1ST)-induced sulfate transfer regulates laminin-binding glycans on α-dystroglycan.
Nakagawa N; Manya H; Toda T; Endo T; Oka S
J Biol Chem; 2012 Aug; 287(36):30823-32. PubMed ID: 22801424
[TBL] [Abstract][Full Text] [Related]
34. Hypoglycosylation of dystroglycan due to T192M mutation: a molecular insight behind the fact.
Bhattacharya S; Das A; Ghosh S; Dasgupta R; Bagchi A
Gene; 2014 Mar; 537(1):108-14. PubMed ID: 24361964
[TBL] [Abstract][Full Text] [Related]
35. Dystroglycan glycosylation and its role in matrix binding in skeletal muscle.
Martin PT
Glycobiology; 2003 Aug; 13(8):55R-66R. PubMed ID: 12736199
[TBL] [Abstract][Full Text] [Related]
36. Cell surface glycan engineering reveals that matriglycan alone can recapitulate dystroglycan binding and function.
Sheikh MO; Capicciotti CJ; Liu L; Praissman J; Ding D; Mead DG; Brindley MA; Willer T; Campbell KP; Moremen KW; Wells L; Boons GJ
Nat Commun; 2022 Jun; 13(1):3617. PubMed ID: 35750689
[TBL] [Abstract][Full Text] [Related]
37. biAb Mediated Restoration of the Linkage between Dystroglycan and Laminin-211 as a Therapeutic Approach for α-Dystroglycanopathies.
Gumlaw N; Sevigny LM; Zhao H; Luo Z; Bangari DS; Masterjohn E; Chen Y; McDonald B; Magnay M; Travaline T; Yoshida-Moriguchi T; Fan W; Reczek D; Stefano JE; Qiu H; Beil C; Lange C; Rao E; Lukason M; Barry E; Brondyk WH; Zhu Y; Cheng SH
Mol Ther; 2020 Feb; 28(2):664-676. PubMed ID: 31843448
[TBL] [Abstract][Full Text] [Related]
38. LARGE glycans on dystroglycan function as a tunable matrix scaffold to prevent dystrophy.
Goddeeris MM; Wu B; Venzke D; Yoshida-Moriguchi T; Saito F; Matsumura K; Moore SA; Campbell KP
Nature; 2013 Nov; 503(7474):136-40. PubMed ID: 24132234
[TBL] [Abstract][Full Text] [Related]
39. Chemical and Chemo-Enzymatic Syntheses of Glycans Containing Ribitol Phosphate Scaffolding of Matriglycan.
Tamura JI; Tamura T; Hoshino S; Imae R; Kato R; Yokono M; Nagase M; Ohno S; Manabe N; Yamaguchi Y; Manya H; Endo T
ACS Chem Biol; 2022 Jun; 17(6):1513-1523. PubMed ID: 35670527
[TBL] [Abstract][Full Text] [Related]
40. Dystroglycan and muscular dystrophies related to the dystrophin-glycoprotein complex.
Sciandra F; Bozzi M; Bianchi M; Pavoni E; Giardina B; Brancaccio A
Ann Ist Super Sanita; 2003; 39(2):173-81. PubMed ID: 14587215
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
